Mark Warne Purchases 50,006 Shares of IXICO (LON:IXI) Stock

IXICO plc (LON:IXI) insider Mark Warne acquired 50,006 shares of IXICO stock in a transaction on Wednesday, July 15th. The shares were bought at an average price of GBX 8 per share, with a total value of £4,000.48.

IXICO Price Performance

Shares of LON IXI opened at GBX 8 on Friday. The company has a debt-to-equity ratio of 5.22, a current ratio of 2.83 and a quick ratio of 4.90. The stock has a market capitalization of £17.52 million, a price-to-earnings ratio of -4.10, a PEG ratio of -0.38 and a beta of 0.13. The firm’s 50 day simple moving average is GBX 8.27 and its 200-day simple moving average is GBX 8.66. IXICO plc has a 12 month low of GBX 6.26 and a 12 month high of GBX 15.

IXICO (LON:IXI) last issued its quarterly earnings data on Tuesday, May 19th. The company reported GBX (1.21) earnings per share for the quarter. The firm had revenue of GBX 395 million during the quarter. IXICO had a negative return on equity of 16.18% and a negative net margin of 24.98%. Analysts expect that IXICO plc will post -289.3584879 EPS for the current year.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.